Novel therapeutic strategy based on genetic and epigenetic abnormalities for myeloid neoplasms

被引：0
作者：
Yamauchi, Takahiro [1 ]
机构：
[1] Univ Fukui, Dept Hematol & Oncol, 23-3 Shimoaizuki, Fukui 9101193, Japan
来源：
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 24卷 / 08期
关键词：
CLASSIFICATION;
D O I：
10.1007/s10147-019-01466-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：883 / 884
页数：2
相关论文
共 11 条
  • [1] The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
    Arber, Daniel A.
    Orazi, Attilio
    Hasserjian, Robert
    Thiele, Jurgen
    Borowitz, Michael J.
    Le Beau, Michelle M.
    Bloomfield, Clara D.
    Cazzola, Mario
    Vardiman, James W.
    [J]. BLOOD, 2016, 127 (20) : 2391 - 2405
  • [2] Do cytogenetics affect the post-remission strategy for older patients with AML in CR1?
    Foran, James M.
    [J]. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2017, 30 (04) : 306 - 311
  • [3] Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
    Ley, Timothy J.
    Miller, Christopher
    Ding, Li
    Raphael, Benjamin J.
    Mungall, Andrew J.
    Robertson, A. Gordon
    Hoadley, Katherine
    Triche, Timothy J., Jr.
    Laird, Peter W.
    Baty, Jack D.
    Fulton, Lucinda L.
    Fulton, Robert
    Heath, Sharon E.
    Kalicki-Veizer, Joelle
    Kandoth, Cyriac
    Klco, Jeffery M.
    Koboldt, Daniel C.
    Kanchi, Krishna-Latha
    Kulkarni, Shashikant
    Lamprecht, Tamara L.
    Larson, David E.
    Lin, Ling
    Lu, Charles
    McLellan, Michael D.
    McMichael, Joshua F.
    Payton, Jacqueline
    Schmidt, Heather
    Spencer, David H.
    Tomasson, Michael H.
    Wallis, John W.
    Wartman, Lukas D.
    Watson, Mark A.
    Welch, John
    Wendl, Michael C.
    Ally, Adrian
    Balasundaram, Miruna
    Birol, Inanc
    Butterfield, Yaron
    Chiu, Readman
    Chu, Andy
    Chuah, Eric
    Chun, Hye-Jung
    Corbett, Richard
    Dhalla, Noreen
    Guin, Ranabir
    He, An
    Hirst, Carrie
    Hirst, Martin
    Holt, Robert A.
    Jones, Steven
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (22) : 2059 - 2074
  • [4] Gene mutations of acute myeloid leukemia in the genome era
    Naoe, Tomoki
    Kiyoi, Hitoshi
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (02) : 165 - 174
  • [5] Genetics of MDS
    Ogawa, Seishi
    [J]. BLOOD, 2019, 133 (10) : 1049 - 1059
  • [6] Genomic Classification and Prognosis in Acute Myeloid Leukemia
    Papaemmanuil, Elli
    Gerstung, Moritz
    Bullinger, Lars
    Gaidzik, Verena I.
    Paschka, Peter
    Roberts, Nicola D.
    Potter, Nicola E.
    Heuser, Michael
    Thol, Felicitas
    Bolli, Niccolo
    Gundem, Gunes
    Van Loo, Peter
    Martincorena, Inigo
    Ganly, Peter
    Mudie, Laura
    McLaren, Stuart
    O'Meara, Sarah
    Raine, Keiran
    Jones, David R.
    Teague, Jon W.
    Butler, Adam P.
    Greaves, Mel F.
    Ganser, Arnold
    Doehner, Konstanze
    Schlenk, Richard F.
    Doehner, Hartmut
    Campbell, Peter J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (23) : 2209 - 2221
  • [7] New drugs for acute myeloid leukemia inspired by genomics and when to use them
    Pollyea, Daniel A.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2018, : 45 - 50
  • [8] How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes
    Steensma, David P.
    [J]. BLOOD, 2018, 132 (16) : 1657 - 1663
  • [9] Myelodysplastic syndromes current treatment algorithm 2018
    Steensma, David P.
    [J]. BLOOD CANCER JOURNAL, 2018, 8
  • [10] Updates in Cytogenetics and Molecular Markers in MDS
    Tiu, Ramon V.
    Visconte, Valeria
    Traina, Fabiola
    Schwandt, Anita
    Maciejewski, Jaroslaw P.
    [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (02) : 126 - 135
12